Daito Pharmaceutical Co.,Ltd. 4577Short Interest
No institution currently reports a short position of 0.5% or more in Daito Pharmaceutical Co.,Ltd. (4577). The last disclosure was on 2026-08-17 (Nomura International plc, 0.48%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
31 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 3 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2018-03-20 |
|---|---|
| Latest disclosure | 2026-08-17 (Nomura International plc, 0.48%) |
| Reporting institutions | 5 firms (31 reports) |
| Peak estimated short interest | 1.33% (2026-05-07, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 4 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Integrated Core Strategies (Asia) Pte. Ltd.
- Nomura International plc
- Diversified Select Opportunities Capital Management, LLC
- Barclays Capital Securities Ltd
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2024-07-22 | Diversified Select Opportunities Capital Management, LLC | Position 77,000 shares | Ratio 0.49% | ▼0.08% | Below 0.5% |
| 2026-08-17 | Nomura International plc | Position 140,441 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2026-07-13 | Barclays Capital Securities Ltd | Position 123,908 shares | Ratio 0.42% | ▼0.12% | Below 0.5% |
| 2018-04-25 | Morgan Stanley & Co. International plc | Position 0 shares | Ratio 0.00% | ▼0.79% | Closed |
| 2021-11-30 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 200 shares | Ratio 0.00% | ▼1.06% | Closed |
Disclosure History 31 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-08-17 | Nomura International plc | Position 140,441 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2026-08-12 | Nomura International plc | Position 173,067 shares | Ratio 0.59% | ▼0.02% | — |
| 2026-07-30 | Nomura International plc | Position 177,165 shares | Ratio 0.61% | ▲0.07% | — |
| 2026-07-14 | Nomura International plc | Position 157,964 shares | Ratio 0.54% | ▼0.09% | — |
| 2026-07-13 | Barclays Capital Securities Ltd | Position 123,908 shares | Ratio 0.42% | ▼0.12% | Below 0.5% |
| 2026-06-29 | Nomura International plc | Position 182,677 shares | Ratio 0.63% | ▼0.07% | — |
| 2026-06-24 | Nomura International plc | Position 202,817 shares | Ratio 0.70% | ▲0.01% | — |
| 2026-06-23 | Nomura International plc | Position 201,088 shares | Ratio 0.69% | ▼0.07% | — |
| 2026-06-02 | Barclays Capital Securities Ltd | Position 163,508 shares | Ratio 0.54% | ▲0.25% | — |
| 2026-05-27 | Nomura International plc | Position 230,116 shares | Ratio 0.76% | ▼0.06% | — |
| 2026-05-11 | Barclays Capital Securities Ltd | Position 95,608 shares | Ratio 0.31% | ▼0.20% | Below 0.5% |
| 2026-05-07 | Nomura International plc | Position 246,936 shares | Ratio 0.82% | ▲0.05% | — |
| 2026-04-30 | Barclays Capital Securities Ltd | Position 155,908 shares | Ratio 0.51% | ▲0.10% | — |
| 2026-04-15 | Nomura International plc | Position 233,274 shares | Ratio 0.77% | ▼0.05% | — |
| 2026-03-31 | Nomura International plc | Position 249,076 shares | Ratio 0.82% | ▲0.04% | — |
| 2026-03-19 | Nomura International plc | Position 235,902 shares | Ratio 0.78% | ▲0.14% | — |
| 2026-03-13 | Nomura International plc | Position 193,430 shares | Ratio 0.64% | ▲0.24% | — |
| 2026-01-29 | Nomura International plc | Position 56,753 shares | Ratio 0.18% | ▼0.34% | Below 0.5% |
| 2026-01-27 | Nomura International plc | Position 158,726 shares | Ratio 0.52% | ▲0.09% | — |
| 2024-07-22 | Diversified Select Opportunities Capital Management, LLC | Position 77,000 shares | Ratio 0.49% | ▼0.08% | Below 0.5% |
| 2024-07-18 | Diversified Select Opportunities Capital Management, LLC | Position 90,900 shares | Ratio 0.57% | ▼0.05% | — |
| 2024-07-16 | Diversified Select Opportunities Capital Management, LLC | Position 98,100 shares | Ratio 0.62% | ▲0.11% | — |
| 2024-07-10 | Diversified Select Opportunities Capital Management, LLC | Position 81,000 shares | Ratio 0.51% | ▲0.11% | — |
| 2021-11-30 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 200 shares | Ratio 0.00% | ▼1.06% | Closed |
| 2021-11-29 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 146,700 shares | Ratio 1.06% | ▲0.13% | — |
| 2021-11-26 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 129,400 shares | Ratio 0.93% | ▲0.12% | — |
| 2021-11-25 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 111,800 shares | Ratio 0.81% | ▲0.09% | — |
| 2021-11-24 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 99,500 shares | Ratio 0.72% | ▲0.19% | — |
| 2021-11-19 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 73,400 shares | Ratio 0.53% | ▲0.13% | — |
| 2018-04-25 | Morgan Stanley & Co. International plc | Position 0 shares | Ratio 0.00% | ▼0.79% | Closed |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Nano Holdings,Inc.4571 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Carna Biosciences,Inc.4572 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAIKO PHARMACEUTICAL CO.,LTD.4574 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CanBas Co.,Ltd.4575 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| D.Western Therapeutics Institute, Inc.4576 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Otsuka Holdings Co.,Ltd.4578 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |